Each: A Randomised Phase Ii Study Evaluating The Safety And Anti-Tumour Activity Of The Combination Of Avelumab And Cetuximab Relative To Avelumab Monotherapy In Recurrent/Metastatic Head And Neck Squamous Cell Cancer.
JOURNAL OF CLINICAL ONCOLOGY（2019）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要